Contaminated drugs are held responsible for 120 deaths in PakistanBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e951 (Published 07 February 2012) Cite this as: BMJ 2012;344:e951
- Sophie Arie
Authorities in Pakistan have temporarily closed a drug company thought to have produced contaminated drugs that killed more than 120 patients at a Lahore hospital over the past month.
The crisis has raised concern over the quality of low cost drugs and the effectiveness of the drug regulatory system in Pakistan.
A batch of the drug, Isotab (containing isosorbide mononitrate 20 mg), is thought to have caused the deaths at the state run Punjab Institute for Cardiology in Lahore, where it was given free of charge to patients with heart conditions. Tests …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial